READ ALL »
Important U of Washington study published
FLC tumors contain a unique genetic defect that fuses together portions of genes called DNAJ and PKAc. DNAJ helps fold other proteins into their correct shapes, whereas PKAc is an enzyme involved in cell communication. An FCF supported research team at the University of Washington, Seattle now report that the DNAJ-PKAc fusion additionally recruits […]
St. Jude Children’s Research Hospital and University of Tennessee co-host major fibrolamellar research collaboration summit focused on immunotherapy
The summit brought together some of the most innovative researchers, clinicians and funders serving the FLC community, including Johns Hopkins, Rush University, University of Maryland, along with co-hosts St. Jude Children’s Research Hospital and U of Tennessee and The Fibrolamellar Cancer Foundation. The meeting highlighted many of the latest discoveries in FLC immunotherapy which were […]
A Great Opportunity to Get Involved in the Fibrolamellar Fight!
The Department of Defense (DOD) is seeking 2019 PATIENT & CAREGIVER Grant reviewers for four cancer categories appropriate for the Fibro community: 1.Cancer in Children, Adolescents and young adults 2. Liver Cancer 3. Immunotherapy 4. Rare Cancers (New Category) Friends from this fibrolamellar community have been very active participants over the past four years and the new categories make this […]
Cowboy event benefited Fibro
A young boy is currently cancer free thanks to a liver transplant from his Dad. An appreciative grandmother planned a wonderful cowboy themed event which happened in the Phoenix area April 2019 and raised funds for FCF. Details are in this news coverage from Peoria Times.
Faces of Fibro Research